ALX Oncology Holdings Inc (ALXO)
1.29
-0.04
(-3.01%)
USD |
NASDAQ |
Nov 15, 16:00
1.29
0.00 (0.00%)
After-Hours: 18:49
ALX Oncology Holdings Total Return Level: 1.33 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 1.33 |
November 13, 2024 | 1.34 |
November 12, 2024 | 1.34 |
November 11, 2024 | 1.48 |
November 08, 2024 | 1.45 |
November 07, 2024 | 1.51 |
November 06, 2024 | 1.53 |
November 05, 2024 | 1.52 |
November 04, 2024 | 1.49 |
November 01, 2024 | 1.45 |
October 31, 2024 | 1.43 |
October 30, 2024 | 1.38 |
October 29, 2024 | 1.40 |
October 28, 2024 | 1.46 |
October 25, 2024 | 1.47 |
October 24, 2024 | 1.455 |
October 23, 2024 | 1.66 |
October 22, 2024 | 1.50 |
October 21, 2024 | 1.50 |
October 18, 2024 | 1.48 |
October 17, 2024 | 1.51 |
October 16, 2024 | 1.56 |
October 15, 2024 | 1.56 |
October 14, 2024 | 1.55 |
October 11, 2024 | 1.54 |
Date | Value |
---|---|
October 10, 2024 | 1.44 |
October 09, 2024 | 1.62 |
October 08, 2024 | 1.65 |
October 07, 2024 | 1.59 |
October 04, 2024 | 1.68 |
October 03, 2024 | 1.72 |
October 02, 2024 | 1.83 |
October 01, 2024 | 1.86 |
September 30, 2024 | 1.82 |
September 27, 2024 | 1.97 |
September 26, 2024 | 1.87 |
September 25, 2024 | 1.81 |
September 24, 2024 | 1.95 |
September 23, 2024 | 1.99 |
September 20, 2024 | 2.07 |
September 19, 2024 | 2.17 |
September 18, 2024 | 2.14 |
September 17, 2024 | 2.18 |
September 16, 2024 | 2.18 |
September 13, 2024 | 2.22 |
September 12, 2024 | 2.14 |
September 11, 2024 | 2.18 |
September 10, 2024 | 2.16 |
September 09, 2024 | 2.10 |
September 06, 2024 | 1.91 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.33
Minimum
Nov 14 2024
112.26
Maximum
Dec 10 2020
26.08
Average
13.30
Median
Aug 29 2022
Total Return Level Benchmarks
Biomarin Pharmaceutical Inc | 65.60 |
Neurocrine Biosciences Inc | 122.88 |
Eton Pharmaceuticals Inc | 10.46 |
Verve Therapeutics Inc | 5.38 |
Immuneering Corp | 1.94 |